pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-2110 |
Genomic Coordinates | chr10: 114174105 - 114174179 |
Synonyms | hsa-mir-2110, MIR2110 |
Description | Homo sapiens miR-2110 stem-loop |
Comment | Zhu et al. incorrectly referred to this sequence as mir-1309 in . This sequence is unrelated to MIR1309 in plants. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-2110 | ||||||||||||||||||||||||||||||||||||||||||
Sequence | 8| UUGGGGAAACGGCCGCUGAGUG |29 | ||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||||||||
Experiments | 454 | DRVs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PFKFB2 | ||||||||||||||||||||
Synonyms | PFK-2/FBPase-2 | ||||||||||||||||||||
Description | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | ||||||||||||||||||||
Transcript | NM_006212 | ||||||||||||||||||||
Other Transcripts | NM_001018053 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PFKFB2 | |||||||||||||||||||||
3'UTR of PFKFB2 (miRNA target sites are highlighted) |
>PFKFB2|NM_006212|3'UTR 1 CCGAAGACCCAAGTCAGCATTCCGGTGGTGTAACTGTGTGTTTCCCTCCAGCCCTGGCCTCCTGCCCTTGTCACTAATCA 81 CCAAGGAGTCATTAACTTCCTCCCTCTATGCCCACCCCTGACACTTCACCATTAATCTTAACACAGAACATGAGGTTATG 161 TGTTTATAGGACAACTTAAGCTGTTCTTCAGTTTGAAACATCTTTTCACCCAGGGGCAAGTTAGCAAATTGAGTCTTTTA 241 GGACAGATTCTCAGATGGGATGATCTGGAGGAGGAGGAAAAAGATACACTCCCTTGGGGCTGAGCATGCCCCACACTCTT 321 GGATCTTCTCTCTGTTCCCTGGTGTCTTCACTAATGTCCTCATGTTGGTGAAGTGTTGGGGGATGGAGGGCGGGTGAGCA 401 GTCGGGGGACAAAAAGTCTATTTTTCCTTCACTTTTGTCTCTTCAATGTGTGTTTTCCTCACACTCCTTACTTGACTGCT 481 TTCTTCCCCCACTTTCATGTCCCCTCTGGATTGTCCAGTGTAATGCATGGCATTGTGGTGTCTGTCTAGGAAGGAAGGGG 561 TGATTGACAAGAGACAAGTCTGGCCCAGTTAATGCTTTCTGCAGTGGGTCTAAATGGATCTGGACTGGAGGAGTCTTTCC 641 TTTCCTTTCTCCCTTCCTCTCCAGCCAGGTCCTGTAAGGGCCAGCCCAGACTACAGGACATCCACAGAATATTCTGGAGC 721 TTGCAAGTAGACATAGGGTGAGAGTTCTTGCCTCCTTTCATGAGAAACAGTTCTAAGTCTTCGATGCCCTGGGAGAATCT 801 GGCTCTGAGCATGTGGGAAATGTCTTGGTTTTTATTTTTAATTTAGAGTCAGGCCTGGGTCTTTTGAGGTCTGCAGAGTG 881 GGGTTTAGGAGAGTAGGGTGGGCTCTAGCTCTTGCAGGGCTCTTAGAGAGCAGTCATGTCTTTTCTCCCATGACTCTCAG 961 GTTCTTTGCCAATCACAGCAACTTTTCCTGCCAAAGCCAGTATCCTCTGGGGCTGTTTAGAAGGGCAGTTAGATTCAGGA 1041 GTCACCACTGATGTTTGAGTTGCTCAAGGCAAGAGGCAGAGAAGAGTTCACTAAAACTGCTTATTTTTGAATAATTTCAG 1121 CACACTGTCCTTAAGAAGAAAGAAACATCAAAACAAAATAGTTTTTACATGACCATTTTTTTCCCAAATGTGGAAAAGCT 1201 TGATGATGAATTTAATCTCTCTCATTGGAGTATTCTTTTGTTCATAAAGAGAAACTATCTCATCTTGATGTCCAGAGAAG 1281 TCCTTGGAACCCTGTGGGATCTAGCTCGTAACTGTTTGTATTTCTCTATTCACTTCTGTCATTTCATTTTCTTTGTAGGG 1361 TTAAACAGAAAATGTTTAGGGAAGAAATTCTTAGCCCCTTGATGACCATGATGGCTTATTCTCTTTCCCAATTTTGCATG 1441 CAAAATGTACGAATATATGTATGTTTTTCTGAGAGGCAAGTTTAGGGTTCTCATGGGATTTTAAAAAGAGATAGGTGACT 1521 CCCCACCTTAAAGTTATCTGCTGGTCTTTTAGAGGTAACCAGTGAGAAGGAGTTAGCTATTTTCCAAGGGTGTTTTCATT 1601 TGGTAATGGAAGACTTTTTGCTGTGGTTCTCATCCAGGAGTATTCCTTAGAATTGCCTTTAGGATTGTTGAATCATAAAC 1681 ATGCCTGTGTCCACCTTATGCTTAATACTGACTCAGAATCTCTGGGATCTGGGTCTGGACATGCATGTATTTAAGTAGCT 1761 TCCCGGATGATTCTGATTCATAGCTCGGGTTAAGAACTCCACCTTAGGAAGTTAGGTGGAAAAATACTGGATAGTAGTTT 1841 CTCAGACAAAAGTGTCAGCCTAGGAATTCTGAATTCCTCATAGTCCTGAAAGGACAGTTCTTTGGGTTTGATGTTTGAGC 1921 AGATCATAATGTTAAATGATATAACCCCCTGGAAGGCAGGCTGCTGTGTTTTAGAGGGTTATTCTAGGTTCTAGTCCCAT 2001 CTTTAACCCTTTACATTGCTGAGTGATGTGGAACAAATCACTGAATTAAATAATTGTCTCTAGAGAGCAGCTGGGGATTT 2081 TAAGCACCCTGGAGAGAGGTGCAGACCCTGCCAGGATGATAAAGGTTGTCATCACTGGCAACTGACTCCTGACCCCGGGT 2161 CCTTTACTCGTATGTCCCAAGTAGGATACCATAGGCAGCTTCTAAAGGCTGCTTACCTAGATTCTTCTCAAAATTGTGTC 2241 CAAGATGTTAAGTAACCTGCTATTCCTGTTTAGTGGTTACATAACATGTACTTAGTGTCTTTGTGGAGCTTTGGGCTGGT 2321 AGGGGCAGGGATAGGGGAAAGCTAAACAGAAGTAGAAGAAAAGGTCCTTGTCCAGAGGAAGGTTATTTTAAGAGACAGGA 2401 CATGTAATTTATAACAAATGGACATTTGCAATATAGCAACAGTCTGAGTCTAGAAGTGTTCAACCATCACATCGCTTCTC 2481 CTGACTTTTCTGTTGTCCTATGGCTATGAGACTACAGGGGTTGGGGGATGGGGATGCCCCCACCACCACCAGTGTGAGAA 2561 TGAGATATGGTTGGGGAGGCGTGTTTGGCACTTTTACAAGGTTGCATTGTCCACATTTGCTTGGATGGTGGCATCTGTAG 2641 CCCAAATGGGCATTCAGTCTTTTCTTCTGCTGTGAGGTAAGAGTAATTCAGACCTAATGAATGAGAAGAGGGAGCACTTT 2721 GATCCACAGACTTTGGATTAACACTGTACCCACTCTTAGCAAAAGGGGACTTCTCTAACAAGCTAGCATTGTGTTAACCT 2801 GTCATTAACCCAGCATTAGAGACAGGTCACTGGGATGTTCATTCTGGCTCTCAGCCTGCTGTTATTTCCCCACTCTCACC 2881 TGTGCTAGTTCGCTTTCTCCAGAAGAGGAGCTGAGGTGGTCTTATCCTCAGATAGGACATGAGAAATTGGAATTTGGCAA 2961 GCAAGGGCTTCAGCATCCTTTAGTTTCTAAAGCAAGATCCCTTCAGAGAAGTCTAGCAGGAAGAAGCCAGGAGAATGTAG 3041 AATGGAAAAGAGCTCTTACTCCAAATTTTAGAGAAGTTTCAGCTCTACTTCTCATCTTTTCTCTCCTGGTCTTACTTGAA 3121 TGCATGTTGGTAATCTGTATACATTACTATGACTGTGTCTATCACAAGTCCTACAAAATAAAAATGGACTTAAAAGTACT 3201 CTCTGCTGAGGCTGTAAGTTTTGTTTTGTGAGAAATAGGTAAAGACATTAGCATTTAATCTACTGGAATAAGCTGGTTGC 3281 TGTGGCTTATACCTGTAGTCCCAGATACTTGGGAGGCTGAGGCAGGAGAATCACTTGAGACCAGCCTGGGCAATATAGTG 3361 AGACCTCACCTCTAAAAAAGTTTTTTATAAATTTACTTGTCTAAAGTGGGGAAAGGGAAATTATTCTGTTTTCTTATTCT 3441 TGCTTCAAGACTATGACAGATTTGAAAGAGAATTCTAAAGCAGATTTAGAGAACCTGCTTCTCTTCTTATCTCCTAATCC 3521 CTAAATTGTAATTTAGCTCTTATCTGTATTGTTGTTTTGTTTTGGTAAAGGGATGATTTTTACATTGAGTTTTAAAGTAG 3601 AATAAGAAAAGCTTCTAAAAACTTGCATTGTGCTAGGGATCTGCCCTATATCTTTGCCTCTGGTGTTTCGTTGTTGTTGT 3681 TATTGTTTGTTTGTTTCCAAAGAAGTTGGAGTTAAGGACACAATATATTTGTACCCCTAGACTGAATGGGTGAGTATTCC 3761 ATATGAGGATCTGGGTAATCCTCTTTGCAACCCACATTTGGTCTTCAGAGACACTGGCATTTTGAAGAAACATATGATAT 3841 AGCTGTTTGGAAATAAATTCATCTATGTTACTTTTTTTTTCTTTTTTTTTTTTTTTTATGAGCAGGAGATCTTAATTGAC 3921 AGAAACTCATTGGTGGTTGGAGTGGCCAATGGGCACGGGAAAAAGTATCCAGTAATCAGAAGAATTGTATCTGGGTTATG 4001 TAATCTTATGCACATTCCATTGTCTTTGCCAAGCCCAGAAGCCATGTTGTGTTCATTGTTAAGAAATTTGATAGATTTAC 4081 CCAGCTTTTCTATGTATTTTGACTTATTGAAAATATGTAACAACTGAGTCGGGTTGCAGCACTGGTGGGGTAGAATCGAC 4161 TTTCCCTGAAGGTGACACAGATGTCAGAATTGTGTCCAGGGATTTAATTTAGACCCATACTGTCCAGGAGACTGTCTCTA 4241 GTTGGATCTCTGTGCTGACTGACTGACAGACAGACTTTAGTGTCTGTGTGCTGACTGACAGACTCTAGTAGTGTCTATAT 4321 GTTGACCAACTGGTAGACCAGGAGGATCTGTGTGCTGATTGACTCTAGTAGGATCTGTTTGTCACTGACAGACTGTAGTA 4401 GTGTCTGTGTGCTGACTGATAGATAGACTATAGTAAAATTTGGGTGTTGCCTGACTAACGGTCTAGGGTCTGTAAGCTGA 4481 CAGTCTGCCTGCTTTCTGATTGTATCCATTGAAGTGTATGTACATTATGGTAATTCTCTGTCTATTAAATGTGTCTAACA 4561 AAGGAAGGAATTAAGCACTCCACGTGTTTTCTTTATAGGGGAGTTCTGTACACTATGATTTTAAATAGATATTTCTTATA 4641 TAGTAGTGGCCAAATTCTCATTATTTTGTACAAGATAAAGGTTATGCATCACTTTTATGGTATTTTGTGAACTCAGCTAA 4721 GGGAATGCCTGTTCAGAGCCTGGAGTTGTTACCTTTACTTGAAGTCATCTCATCCAGTCCCCTGCTTTAGGGCAGGACTT 4801 CAGTTCCACTGTTCATTTCTGAAGCTTCTGTGTCCCCAGCTTACCCTGTTCTGAAATGTTGTATTCCATTGGACAGGGCT 4881 GCTATTTTTAGTCAGCCATGCATTTGGATTTTACACTTAATCTAGTAAGTAAAAATGAGAAGAAAATTTGGCATTTAAAA 4961 ATTGATTTTAAGGGTTGGCAAAAGTATTTTTTCCAGTAAGCCTTTCACTGGATATCTGTGACCAATGTTTACCTACGCAA 5041 TGTTTTTGTATCTGAATTGCTTATGTACGTTTTTTATTATATTGACCTAACAAGAAGATCAACTTATGCTGGTATGGTGA 5121 TGGTTTTGCTATGGCAAAATCAAAGGGCTGATCATACATGGTGCCCTTTGGGAAGGGGGATGGTGTGGGGCTGAGCACCT 5201 CTGGGTTGAATGGGAATGGGTCAGATTGGGAAGCCTAGGAAGAGAGTTCTACTGTAGATTTCCTAGGCACTGCTCTGTTG 5281 AAATAGGAACATAAGTCTTTAGCAACATTCTGATTTAATCGGGTGACACTGATAACAAAGTATGCCACTCAGATCCATTT 5361 AAAGTGTGCATAACTGTATTTGAAATGTGTTTTTGTGTGCGTGTGTGTAGAATGGGTAAATAAAATTGTTGAGTAACTTG 5441 AACCTA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000367080.3 | 3UTR | UUAUUUCCCCACUCUCACCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
96 hsa-miR-2110 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT035757 | BRD4 | bromodomain containing 4 | 1 | 1 | ||||||||
MIRT035758 | NCOR2 | nuclear receptor corepressor 2 | 1 | 1 | ||||||||
MIRT035759 | FASN | fatty acid synthase | 1 | 1 | ||||||||
MIRT035760 | C10orf118 | coiled-coil domain containing 186 | 1 | 1 | ||||||||
MIRT055403 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 6 | ||||||||
MIRT066205 | MARCH9 | membrane associated ring-CH-type finger 9 | 2 | 2 | ||||||||
MIRT079365 | CCDC137 | coiled-coil domain containing 137 | 2 | 2 | ||||||||
MIRT081180 | MIDN | midnolin | 2 | 4 | ||||||||
MIRT082397 | HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U like 1 | 2 | 4 | ||||||||
MIRT089000 | BCL11A | B-cell CLL/lymphoma 11A | 2 | 2 | ||||||||
MIRT133706 | SKI | SKI proto-oncogene | 2 | 4 | ||||||||
MIRT160053 | TET3 | tet methylcytosine dioxygenase 3 | 2 | 4 | ||||||||
MIRT180853 | RPRD2 | regulation of nuclear pre-mRNA domain containing 2 | 2 | 2 | ||||||||
MIRT263243 | SGPL1 | sphingosine-1-phosphate lyase 1 | 2 | 2 | ||||||||
MIRT285532 | CDT1 | chromatin licensing and DNA replication factor 1 | 2 | 2 | ||||||||
MIRT317152 | E2F3 | E2F transcription factor 3 | 2 | 4 | ||||||||
MIRT321166 | EIF4H | eukaryotic translation initiation factor 4H | 2 | 2 | ||||||||
MIRT441482 | NCEH1 | neutral cholesterol ester hydrolase 1 | 2 | 2 | ||||||||
MIRT443884 | CNKSR3 | CNKSR family member 3 | 2 | 2 | ||||||||
MIRT445877 | WBP1L | WW domain binding protein 1 like | 2 | 2 | ||||||||
MIRT446195 | GTPBP4 | GTP binding protein 4 | 2 | 2 | ||||||||
MIRT449308 | MRO | maestro | 2 | 2 | ||||||||
MIRT450301 | DRAXIN | dorsal inhibitory axon guidance protein | 2 | 2 | ||||||||
MIRT450512 | EMX1 | empty spiracles homeobox 1 | 2 | 2 | ||||||||
MIRT451534 | CIAPIN1 | cytokine induced apoptosis inhibitor 1 | 2 | 2 | ||||||||
MIRT451820 | ALDH3B1 | aldehyde dehydrogenase 3 family member B1 | 2 | 2 | ||||||||
MIRT452239 | TRAM1 | translocation associated membrane protein 1 | 2 | 2 | ||||||||
MIRT454207 | HLA-A | major histocompatibility complex, class I, A | 2 | 2 | ||||||||
MIRT455447 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | 2 | 2 | ||||||||
MIRT456496 | PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | 2 | 2 | ||||||||
MIRT457656 | SERINC1 | serine incorporator 1 | 2 | 2 | ||||||||
MIRT459819 | TPP1 | tripeptidyl peptidase 1 | 2 | 2 | ||||||||
MIRT460556 | FEM1A | fem-1 homolog A | 2 | 2 | ||||||||
MIRT462561 | STS | steroid sulfatase | 2 | 2 | ||||||||
MIRT462986 | ZNF740 | zinc finger protein 740 | 2 | 2 | ||||||||
MIRT464671 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 2 | ||||||||
MIRT465432 | TP53 | tumor protein p53 | 2 | 2 | ||||||||
MIRT465934 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 2 | ||||||||
MIRT466015 | TMEM189 | transmembrane protein 189 | 2 | 2 | ||||||||
MIRT468122 | SH3PXD2A | SH3 and PX domains 2A | 2 | 2 | ||||||||
MIRT469652 | RAC1 | Rac family small GTPase 1 | 2 | 2 | ||||||||
MIRT469980 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 2 | 2 | ||||||||
MIRT473531 | MAX | MYC associated factor X | 2 | 2 | ||||||||
MIRT473596 | MARK2 | microtubule affinity regulating kinase 2 | 2 | 2 | ||||||||
MIRT473652 | MARCKSL1 | MARCKS like 1 | 2 | 2 | ||||||||
MIRT474219 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 4 | ||||||||
MIRT474771 | KIAA0895L | KIAA0895 like | 2 | 2 | ||||||||
MIRT479312 | VPS72 | vacuolar protein sorting 72 homolog | 2 | 2 | ||||||||
MIRT481121 | AZIN1 | antizyme inhibitor 1 | 2 | 4 | ||||||||
MIRT481682 | AR | androgen receptor | 2 | 2 | ||||||||
MIRT482381 | AEN | apoptosis enhancing nuclease | 2 | 2 | ||||||||
MIRT483833 | UNC5B | unc-5 netrin receptor B | 2 | 4 | ||||||||
MIRT484693 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT485238 | POGZ | pogo transposable element derived with ZNF domain | 2 | 2 | ||||||||
MIRT488748 | FXYD1 | FXYD domain containing ion transport regulator 1 | 2 | 2 | ||||||||
MIRT489147 | MRPL12 | mitochondrial ribosomal protein L12 | 2 | 4 | ||||||||
MIRT489518 | MRE11A | MRE11 homolog, double strand break repair nuclease | 2 | 8 | ||||||||
MIRT498908 | SRCAP | Snf2 related CREBBP activator protein | 2 | 2 | ||||||||
MIRT506426 | NAGK | N-acetylglucosamine kinase | 2 | 6 | ||||||||
MIRT506640 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 4 | ||||||||
MIRT507332 | FAM168A | family with sequence similarity 168 member A | 2 | 2 | ||||||||
MIRT513099 | DYNAP | dynactin associated protein | 2 | 2 | ||||||||
MIRT513514 | YIPF4 | Yip1 domain family member 4 | 2 | 6 | ||||||||
MIRT521800 | POM121C | POM121 transmembrane nucleoporin C | 2 | 2 | ||||||||
MIRT525078 | FRK | fyn related Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT530927 | SCIN | scinderin | 2 | 2 | ||||||||
MIRT533498 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT536787 | HNRNPD | heterogeneous nuclear ribonucleoprotein D | 2 | 2 | ||||||||
MIRT544554 | CSNK2A1 | casein kinase 2 alpha 1 | 2 | 2 | ||||||||
MIRT552977 | VAT1 | vesicle amine transport 1 | 2 | 2 | ||||||||
MIRT557358 | HAND1 | heart and neural crest derivatives expressed 1 | 2 | 2 | ||||||||
MIRT560401 | TMEM69 | transmembrane protein 69 | 2 | 2 | ||||||||
MIRT565498 | SP1 | Sp1 transcription factor | 2 | 2 | ||||||||
MIRT568962 | CACNA1C | calcium voltage-gated channel subunit alpha1 C | 2 | 2 | ||||||||
MIRT569031 | IL21R | interleukin 21 receptor | 2 | 2 | ||||||||
MIRT573224 | TRIM21 | tripartite motif containing 21 | 2 | 2 | ||||||||
MIRT574312 | ZNF703 | zinc finger protein 703 | 2 | 2 | ||||||||
MIRT620395 | MYO1H | myosin IH | 2 | 2 | ||||||||
MIRT620936 | OSMR | oncostatin M receptor | 2 | 2 | ||||||||
MIRT638166 | TMED4 | transmembrane p24 trafficking protein 4 | 2 | 2 | ||||||||
MIRT647743 | SAMD9L | sterile alpha motif domain containing 9 like | 2 | 2 | ||||||||
MIRT649991 | MSI1 | musashi RNA binding protein 1 | 2 | 2 | ||||||||
MIRT669203 | CBX8 | chromobox 8 | 2 | 2 | ||||||||
MIRT684546 | ZNF708 | zinc finger protein 708 | 2 | 2 | ||||||||
MIRT685837 | ANGEL1 | angel homolog 1 | 2 | 2 | ||||||||
MIRT688547 | DCAF16 | DDB1 and CUL4 associated factor 16 | 2 | 2 | ||||||||
MIRT693252 | HBS1L | HBS1 like translational GTPase | 2 | 2 | ||||||||
MIRT701970 | MIER3 | MIER family member 3 | 2 | 2 | ||||||||
MIRT706385 | MC2R | melanocortin 2 receptor | 2 | 2 | ||||||||
MIRT707484 | UGT2B4 | UDP glucuronosyltransferase family 2 member B4 | 2 | 2 | ||||||||
MIRT711882 | INSIG2 | insulin induced gene 2 | 2 | 2 | ||||||||
MIRT716906 | CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 | 2 | 2 | ||||||||
MIRT717638 | HLX | H2.0 like homeobox | 2 | 2 | ||||||||
MIRT719058 | ZNF281 | zinc finger protein 281 | 2 | 2 | ||||||||
MIRT723754 | NKIRAS2 | NFKB inhibitor interacting Ras like 2 | 2 | 2 | ||||||||
MIRT725479 | GPR26 | G protein-coupled receptor 26 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|